Nurse Practitioner Pleads Guilty to Health Care Fraud, Unlawful Drug Distribution

ALBANY, NEW YORK -United States Attorney John A. Sarcone III announced today that Anja Salamack, age 50, of Delray Beach, Florida, pled guilty last week to health care fraud and to distributing controlled substances outside the course of professional practice and for no legitimate medical purpose. The charges filed in federal court are part of the Department of Justice's 2025 National Health Care Fraud Takedown.

"Today's record-setting Health Care Fraud Takedown sends a crystal-clear message to criminal actors, both foreign and domestic, intent on preying upon our most vulnerable citizens and stealing from hardworking American taxpayers: we will find you, we will prosecute you, and we will hold you accountable to the fullest extent of the law," said Attorney General Pamela Bondi. "Make no mistake - this administration will not tolerate criminals who line their pockets with taxpayer dollars while endangering the health and safety of our communities."

The charges announced today by U.S. Attorney Sarcone are part of a strategically coordinated, nationwide law enforcement action that resulted in criminal charges against 324 defendants for their alleged participation in health care fraud and illegal drug diversion schemes that involved the submission of over $14.6 billion in alleged false billings and over 15.6 million pills of illegally diverted controlled substances. The defendants allegedly defrauded programs entrusted for the care of the elderly and disabled to line their own pockets. In connection with the Takedown, the Government seized over $245 million in cash, luxury vehicles, and other assets.

Salamack, formerly an Albany resident, was a psychiatric nurse practitioner who resided in Florida but claimed to be practicing in Albany.

Salamack pled guilty to health care fraud for submitting false and fraudulent claims to health care benefit programs in New York State for health care services that she never provided, e.g. psychotherapy services, and evaluation and management services; she caused $163,639.58 in losses.

Salamack also pled guilty to unlawful drug distribution (also known as drug diversion), for issuing prescriptions for the controlled substance amphetamine (e.g. Adderall) for non-medical purposes and outside the usual course of professional practice. For instance, from November 2018 to May 2023, Salamack regularly prescribed amphetamine in the name of a person who had not been her patient since 2016. Salamack issued these prescriptions (108 in total) at the request of a relative of the former patient.

In a separate civil settlement agreement, Salamack admitted that she submitted claims to Medicare for psychotherapy services that were not rendered. She also admitted that she used $48,670 in Provider Relief Funds (PRF) for impermissible purposes. The PRF was money that the Coronavirus Aid, Relief, and Economic Security Act had allocated to healthcare providers to pay for costs associated with the COVID-19 pandemic. Salamack agreed to pay $188,850 to resolve her False Claims Act liability.

United States Attorney John A. Sarcone III stated: "It's sad and shameful for a licensed medical professional to abuse the privilege they have to provide care for people and instead inflict harm on others. This case shows that no matter where you are conducting illegal activities, if what you do impacts the Northern District of New York, you will be prosecuted and punished here. Thanks to a thorough investigation by the DEA and other law enforcement partners, Anja Salamack is out of business and faces the prospect of spending years in federal prison."

"Health care professionals are not above the law and must be held to the highest standards, especially when dealing with controlled substances" stated DEA New York Special Agent in Charge Frank Tarentino. "Anja Salamack knowingly chose to put profits above the health and well-being of those lives she took an oath to help when she unlawfully prescribed the controlled substance amphetamine for non-medical purposes. Salamack's actions were no different from those of any drug trafficker fueling an already deadly and highly addictive opioid crisis."

"Individuals and entities that participate in government programs are required to obey the laws meant to preserve the integrity of program funds and ensure the provision of appropriate, quality services to patients," stated Special Agent in Charge Naomi Gruchacz with the U.S. Department of Health and Human Services Office of Inspector General. "The defendant in this case put patients' wellbeing in jeopardy and exploited vital programs meant to benefit her community."

At sentencing, before United States District Judge Anne M. Nardacci on October 22, 2025, Salamack faces up to 10 years in prison for health care fraud and up to 20 years in prison for drug diversion. She also faces a fine of up to $1 million, as well as at least 3 years of post-imprisonment supervised release. A defendant's sentence is imposed by a judge based on the particular statutes the defendant is convicted of violating, the U.S. Sentencing Guidelines and other factors. Salamack has agreed to pay $163,659.68 in restitution for the health care fraud.

Salamack has already surrendered her DEA registration (which had allowed her to prescribe controlled substances).

The DEA's Tactical Diversion Squad (TDS) investigated this case. TDS is comprised of DEA Special Agents and Diversion Investigators, as well as Investigators from the New York State Department of Health, Bureau of Narcotic Enforcement. The U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG), Department of Defense Office of Inspector General, Defense Criminal Investigative Service, Albany County Sheriff's Office, and the Colonie Police Department assisted the investigation.

Assistant U.S. Attorney Michael Barnett is prosecuting the criminal case and Assistant U.S. Attorney Christopher R. Moran represented the United States in the civil matter.